To match an exact phrase, use quotation marks around the search term. eg. "Parliamentary Estate". Use "OR" or "AND" as link words to form more complex queries.


Keep yourself up-to-date with the latest developments by exploring our subscription options to receive notifications direct to your inbox

Written Question
Leicester Hospital: Kidneys
Monday 2nd March 2020

Asked by: Claudia Webbe (Independent - Leicester East)

Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment has been made of the potential risk to hepatobiliary patients in Leicester of dividing kidney transplant and nephrology services between the Leicester General Hospital and Glenfield Hospital sites.

Answered by Nadine Dorries

The pre-consultation business case on the proposed reconfiguration of three hospitals in Leicester, including Leicester General Hospital, requires approval at a local, regional and national level prior to the commencement of formal public consultation. It is anticipated that this process will soon be completed. Subject to this, a consultation will follow.

In January 2020 the three Clinical Commissioning Groups set out a plan to consult the public. Regular discussions have taken place with the local authorities, councillors and the Health Overview and Scrutiny Committees throughout the development of the proposals. Engagement with the public has also been ongoing. This work has enabled the proposals to be refined and developed taking on board the feedback from the local population.

Leicester’s Hospitals are currently undertaking a transformation of Intensive Care Services, which includes moving the Level 3 Intensive Care Unit and associated services from the Leicester General Hospital to the Leicester Royal Infirmary and Glenfield Hospitals. As part of the complex service moves between sites, there will be a temporary split of nephrology and transplant services between the Leicester General Hospital and Glenfield Hospital. It is not anticipated that there will be any resulting effect on, or risk for hepatobiliary patients, who are cared for under a different clinical service.